Dasatinib's Effects on Melanoma Cells
Author Information
Author(s): Eustace Alex J, Crown John, Clynes Martin, O'Donovan Norma
Primary Institution: National Institute for Cellular Biotechnology, Dublin City University
Hypothesis
Can dasatinib improve treatment outcomes in melanoma cell lines?
Conclusion
Dasatinib has anti-proliferative and anti-invasive effects in melanoma cells and may enhance the efficacy of chemotherapy.
Supporting Evidence
- Dasatinib inhibited growth in three of the five melanoma cell lines tested.
- Combination of dasatinib with temozolomide showed greater efficacy than either drug alone.
- Dasatinib induced cell cycle arrest and apoptosis in sensitive melanoma cells.
- Dasatinib significantly inhibited cell migration and invasion.
Takeaway
Dasatinib is a medicine that helps stop melanoma cells from growing and spreading, especially when used with other cancer drugs.
Methodology
The study examined dasatinib's effects on melanoma cell lines through various assays including proliferation, apoptosis, and migration.
Limitations
The study is limited to in vitro findings and may not fully represent in vivo responses.
Statistical Information
P-Value
0.038, 0.024
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website